BROOKE DUCHARME: Open Payments
NPI 1851872410 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 47 payments from 15 companies in 2025. Trend: 2023 $1,119 · 2024 $867 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Novo Nordisk Inc | 6 | $102 |
| AstraZeneca Pharmaceuticals LP | 5 | $82 |
| PFIZER INC. | 4 | $67 |
| ABBVIE INC. | 3 | $66 |
| Amgen Inc. | 4 | $65 |
| Lilly USA, LLC | 4 | $61 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Exact Sciences Corporation | 2 | $55 |
Products named: CAPLYTA, VRAYLAR, Ozempic, TRELEGY ELLIPTA, REXULTI, Cologuard Collection Kit, NURTEC ODT, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
